Table 2 |
|||
|
Histologic scoring |
|||
|
Tendon parameter |
Fetal-derived embryonic-like stem cell treated tendon |
Placebo control treated tendon |
Two-tailed P |
|
|
|||
|
Cell shape |
1.0 (0.9 to 1.3) |
2.0 (1.8 to 2.3)* |
<0.0001 |
|
Cell density |
1.0 (2.0 to 2.0) |
2.75 (2.3 to 3.0)* |
0.0002 |
|
Free hemorrhage |
1.0 (0.9 to 1.7) |
1.75 (1.1 to 2.4) |
0.1 |
|
Neo-vascularization |
2.0 (1.4 to 2.2) |
2.0 (1.2 to 2.3) |
0.7 |
|
Perivascular cuffing |
1.5 (1.1 to 2.0) |
1.0 (0.83 to 1.4) |
0.1 |
|
Collagen linearity |
2.0 (1.3 to 2.1) |
2.75 (2.4 to 3.0)* |
<0.0001 |
|
Collagen uniformity |
2.0 (1.4 to 2.1) |
3.0 (2.8 to 3.1)* |
<0.0001 |
|
Polarized crimping |
1.5 (1.2 to 2.1) |
3.0 (2.7 to 3.3)* |
<0.0001 |
|
Epitenon thickening |
2.3 (2.0 to 2.6) |
3.0 (2.6 to 3.5)* |
0.0009 |
|
|
|||
|
Cumulative Score |
15.4 (12.6 to 17.8) |
20.8 (19.0 to 23.0)* |
<0.0001 |
|
|
|||
|
Histologic scores for fetal-derived embryonic-like stem cell treated tendon and placebo control treated tendon reported as median (95% confidence interval). Significant differences between treatment groups are marked by an asterisk (two-tailed P < 0.05) and the two-tailed P-values are listed. |
|||
|
Watts et al. Stem Cell Research & Therapy 2011 2:4 doi:10.1186/scrt45 |
|||